Search for: "Covidien AG"
Results 1 - 12
of 12
Sorted by Relevance
|
Sort by Date
9 Jan 2015, 5:32 am
”Bayer Consumer Care AG v. [read post]
19 Dec 2011, 8:58 am
Tissue Science Laboratories Limited is an indirect affiliate of Covidien plc. [read post]
24 Oct 2010, 7:34 am
Specifically, the agents mentioned by the FDA as possibly being more likely to result in the skin condition are GE Healthcare's Omniscan, Bayer AG's Magnevist and Covidien's Optimark. [read post]
2 Dec 2009, 9:23 am
The FDA also found a greater risk for Bayer AG’s Magnevist and Covidien’s Optimark. [read post]
18 Nov 2019, 4:24 am
” Estimates show that nearly 55,000 Americans die each year from a drug overdose, which has sadly become the leading cause of death of individuals under the age of 50. [read post]
28 Sep 2016, 8:39 am
” The argument builds on the non-patent decision Daimler AG v. [read post]
13 Oct 2016, 6:50 am
Sud-Chemie AG, No. 16-238 (unduly narrow claim construction) Claim Construction: Google, Inc. v. [read post]
16 Jan 2017, 5:44 pm
Covidien LP, et al., No. 16-366 (separation-of-function – can the PTO Director delegate IPR institution decisions to PTAB); Same question presented in LifeScan Scotland, Ltd. v. [read post]
6 Apr 2010, 4:56 am
(GRAY on Claims) District Court E D Texas finds Applied Medical Resources liable for infringement of Covidien’s surgical device patent (Patent Docs) District Court E D Texas limits number of patent claims and prior art references asserted in case: SynQor, Inc v Artesyn Technologies, Inc et al (Docket Report) District Court W D Pennsylvania: Non-practising entity entitled to permanent injunction where infringed patent was the subject of prior exclusive license: Judkins v. [read post]
14 Nov 2016, 9:16 am
Sud-Chemie AG, No. 16-238 (unduly narrow claim construction) Eligibility: Trading Technologies International, Inc. v. [read post]
8 Feb 2017, 3:09 am
Sud-Chemie AG, No. 16-238 (unduly narrow claim construction) Eligibility: Trading Technologies International, Inc. v. [read post]
2 Sep 2014, 4:27 am
Paul Pioneer Press article (here), on July 2, 2014, a shareholder of Minnesota-based Medtronic has filed a class action lawsuit in Hennepin County District Court challenging the company’s planned $42.9 billion acquisition of Ireland-based Covidien, which will result in a new company to be called Medtronic PLC. [read post]
